Open Access 01.12.2021 | Correction
Correction to: HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine
Erschienen in: Journal of Hematology & Oncology | Ausgabe 1/2021